WebJan 15, 2024 · In January 2024, JW Therapeutics through its PRC affiliate Shanghai Mingju Biotechnology Co., Ltd. which is a Chinese local company, completed the application for investigating new drug for its CD19 T-cell therapy. In August 2024, Fosun Kite also completed its application for CD19 T-cell therapy with CDE under NMPA in China. WebNov 10, 2024 · Intuitive also recently made its way into early-stage lung cancer detection when it teamed up with China's Fosun Pharma Kite Biotechnology Co. Ltd. to develop a flexible robotic catheter that can navigate into the cavernous regions of the lungs.
China Approves Its First CAR-T Cell Therapy - Caixin Global
WebJun 24, 2024 · As a joint venture between Shanghai Fosun Pharmaceutical (Group) Co., Ltd and Kite Pharma, Inc., Fosun Kite is dedicated to the advancement and commercialization of innovative cell therapies in China to benefit patients. ... US office, expanding its business outreach to a central hub of biotech network. 2024-03-02 18:00. … WebFosun Kite received the first approval of #CART from the #NMPA, the China FDA. Congrats to our colleagues from Fosun Kite!!! I am so proud to be part of the… matt connery facebook
China
WebDec 21, 2024 · FOSUN PHARMA (02196.HK) +0.400 (+1.826%) Short selling $5.87M; Ratio 10.501% announced that Fosun Kite Biotechnology Co., Ltd., invested by the … WebFosun Kite Biotechnology Co., Ltd. Frontiers Media. GlaxoSmithKline (China) Investment Co., Ltd. GlaxoSmithKline (China) R&D Co., Ltd. Global Health Drug Discovery Institute. … matt conley construction